CR1 and leukemia: The CR1 and Rel groups were compared for several different measures of disease progression including time to 1%huCD45+ (TT1%), time to 25%huCD45+ (TT25%) and time to overt symptoms of leukaemia (time to leukaemia, TTL; Fig. 2).